DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hsu C, Lee SH, Ejadi S. et al.
Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study.
J Clin Oncol 2017;
35 (36) 4050-4056
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.